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Purpose: To assess the frequency of mutations in the Myocilin (MYOC) gene in Iranian 
patients affected with primary congenital glaucoma (PCG). 
Methods: The individuals evaluated herein are among a larger cohort of 100 patients 
who had previously been screened for CYP1B1 mutations. Eighty subjects carried 
mutations in CYP1B1, but the remaining 20 patients who did not, underwent screening 
for MYOC mutations for the purpose of the study. MYOC exons in the DNA were 
polymerase chain reaction (PCR) amplified and sequenced. Sequencing was performed 
using PCR primers, the ABI big dye chemistry and an ABI3730XL instrument. 
Sequences were analyzed by comparing them to reference MYOC sequences using 
the Sequencher software. 
Results: Four MYOC sequence variations were observed among the patients, but 
none of them were considered to be associated with disease status. Three of these 
variations were single nucleotide polymorphisms already reported not to be disease 
causing, the fourth variation created a synonymous codon and did not affect any 
amino acid change. 
Conclusion: In this cohort, MYOC mutations were not observed in any Iranian subject 
with PCG. It is possible that in a larger sample, a few subjects carrying disease 
causing MYOC mutations could have been observed. But our results show that the 
contribution of MYOC to PCG status in Iran is small if any.
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INTRODUCTION
Glaucoma affects more than 60 million people 
worldwide and is the second leading cause of 
blindness.1 It has traditionally been categorized 
based on etiology, anatomy of the anterior 
chamber angle, and age of onset.2 Two of the 
major forms of the disease are primary open 
angle glaucoma (POAG; OMIM 137760) and 
primary congenital glaucoma (PCG; OMIM 
231300). PCG is a severe form of glaucoma 
that manifests at birth or early childhood and 
is associated with developmental defects in 
the trabecular meshwork.3 POAG is the most Myocilin Mutations and PCG; Elahi et al
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common form of glaucoma in Western countries 
and usually affects individuals past the age of 
40 years.2 Genetic analysis has identified more 
than ten loci linked to POAG, attesting to its 
high genetic heterogeneity.4 Genes at three 
of these loci have been identified: Myocilin 
(MYOC at GLC1A; OMIM 601652), Optineurin 
(OPTN at GLC1E; OMIM 602432), and WD 
repeat containing protein 36 (WDR36 at GLC1G; 
OMIM 609669).5-7 Mutations in MYOC have been 
observed more frequently than mutations in 
OPTN and WDR36. Three loci have been found 
for PCG, and genes at two of these loci have 
been identified: the Cytochrome P4501B1 gene 
(CYP1B1 at GLC3A; OMIM 601771) and the 
Latent Transforming Growth Factor (TGF) Beta 
Binding Protein 2 gene (LTBP2 at GLC3C; OMIM 
602091).8,9 CYP1B1 mutations are most common, 
and have been observed in approximately 70% 
of Iranian PCG patients.10 Although CYP1B1 
is generally associated with PCG, several 
studies have reported CYP1B1 mutations in 
POAG patients and it is now apparent that 
this gene can also cause POAG, particularly 
the juvenile onset form of the disease (juvenile 
open angle glaucoma, JOAG).11-14 Less often, 
MYOC mutations have been observed in PCG 
patients.15-17 MYOC mutations were sometimes 
observed in conjunction with CYP1B1 mutations 
and sometimes without CYP1B1 mutations. The 
biological significance of these observations is 
that some cases of PCG and POAG may share 
a common etiology.18 Herein, we report data 
on the frequency of MYOC mutation among 
Iranian PCG patients. 
METHODS
This study was performed in accordance with 
the Declaration of Helsinki and with approval 
by the Ethics Board of the National Institute 
of Genetic Engineering and Biotechnology in 
Iran, and the University of Tehran. Informed 
consent was obtained from all patients or their 
guardians. Originally, 123 unrelated Iranian PCG 
patients were recruited for genetic studies.10,19 
Slitlamp biomicroscopy, intraocular pressure 
(IOP) measurement, gonioscopic evaluation of 
the angle, fundus examination, and perimetry 
had been performed whenever possible. PCG 
manifested by IOP≥ 21 (range, 21-56) mmHg 
in at least one eye before treatment, corneal 
edema and/or opacification, Descemet’s 
membrane rupture, megalocornea (corneal 
diameter exceeding 12 mm), and optic nerve 
head changes suggestive of glaucoma including 
high cup/disc ratio or neural rim thinning or 
notching. The cup/disc ratio of affected eyes 
ranged from 0.3 to total (average value, 0.58). 
Mutation screening for CYP1B1 was performed 
by direct sequencing and 80 patients among the 
initial 123 cases, were shown to have mutations 
in this gene.10,19 Twenty of the remaining 43 
patients were available for further study. 
DNA was extracted from these 20 patients 
and the three MYOC exons were amplified 
by polymerase chain reaction (PCR) and 
subsequently screened for mutations by direct 
sequencing. Sequencing was performed using 
PCR primers and the ABI big dye chemistry and 
an ABI3730XL instrument (Applied Biosystems, 
Foster City, USA). Sequences were analyzed by 
comparing them to reference MYOC sequences 
(NT_004487, NM_000261, and NP_000252) 
using the Sequencher software (Gene Codes 
Corp., Ann Arbor, USA). PCR conditions and 
MYOC primer sequences are available upon 
request. For assessing the frequency of MYOC 
mutations, data on the 80 patients with CYP1B1 
mutations and the 20 patients without CYP1B1 
mutations in whom MYOC was sequenced were 
considered. The 23 patients without CYP1B1 
mutations who were not available for MYOC 
screening were not included in the analysis. 
RESULTS
Overall 20 patients including ten male and 10 
female subjects, all with age of onset of PCG less 
than 3 years, were studied. Sequencing MYOC 
exons revealed four sequence variations. Three 
of these: c.-83G>A, c.227G>A and IVS2+35G>A, 
were observed in heterozygous state each in 6 
distinct individuals and in homozygous state 
in 1, 1 and 6 individuals respectively. All of 
these are single nucleotide polymorphisms 
(SNPs) that have already been reported not to 
be disease causing.20-22 The same variations have Myocilin Mutations and PCG; Elahi et al
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previously been observed as high frequency 
polymorphisms in Iranian JOAG patients.14 
The fourth variation, c.1041T>A, resulting in 
Y347Y, is also very unlikely to be associated with 
disease status because it creates a synonymous 
codon and does not cause any amino acid 
change; it was observed in the heterozygous 
state in one subject. 
DISCUSSION 
We have ascertained that MYOC is not a major 
cause of PCG among Iranian patients. Although 
this gene was sequenced in only 20 patients 
and disease causing mutations were not found, 
these 20 patients are among 100 subjects whose 
status regarding CYP1B1 is already known.10,19 
Of the 100 patients, 80 have been shown to 
harbor disease causing CYP1B1 mutations and 
are unlikely to simultaneously carry MYOC 
mutations. Therefore, it can reasonably be 
surmised that mutations in MYOC mutations 
were not the cause of PCG in 100 recruited 
patients. Studies comparable to ours have 
been reported on PCG patients from India 
and China. In studies from India, four among 
approximately 150 patients (MYOC screened in 
72; the remaining carried CYP1B1 mutations) 
in one study,15 and five among 200 subjects 
in another report16 carried MYOC mutations. 
In a study from China, three patients among 
116 subjects harbored MYOC mutations.17 It 
is possible that in a larger cohort of Iranian 
PCG patients, a few individuals carrying 
disease causing MYOC mutations would have 
been identified. But clearly, the results of this 
study show that the contribution of MYOC 
to PCG status in Iran is small if any. Notably 
the contribution of CYP1B1, which is usually 
associated with PCG, to JOAG has been shown 
to be very significant in Iran.14,23 In fact, MYOC 
and CYP1B1 may contribute equally to JOAG 
status among Iranian patients.14 The explanation 
for this may be that some cases of JOAG may 
be late onset forms of PCG rather than early 
onset forms of POAG. Fewer cases of PCG may 
share a common etiology with classic open 
angle glaucoma.
Since MYOC and CYP1B1 mutations have 
been observed in the same individual in a 
few cases, a digenic mode of pathogenesis for 
glaucoma has sometimes been proposed.15,18 
To the best of our knowledge, the CYP1B1 
mutation in such patients has always been 
R368H.15,16 The proposed digenic mode of 
pathogenesis for PCG should be considered 
with caution because it is not absolutely clear 
that the R368H mutation in CYP1B1 actually 
is a disease associated variation. Its frequency 
in PCG affected and control groups in India 
has been reported to be similar.11 We have 
recently made the same observation among 
Iranian PCG patients and control individuals 
(unpublished data). We have also noted that 
the variation found in PCG patients harboring 
only one mutated CYP1B1 allele is frequently 
R368H, suggesting that it may be a neutral 
polymorphism. Notably, both observations of 
a MYOC mutation coexisting with a R368H 
CYP1B1 allele were made in patients from 
India.15,16 These observations emphasize that it 
is unclear whether MYOC and CYP1B1 work in 
a common pathway toward PCG. The manner 
in which mutations in MYOC may affect PCG 
status remains unknown.
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